File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research
  • Basic View
  • Metadata View
  • XML View
TitleResearch findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research
 
AuthorsAiello, AE11
Coulborn, RM11
Aragon, TJ10
Baker, MG8
Burrus, BB2
Cowling, BJ4
Duncan, A8
Enanoria, W10
Fabian, MP12 3
Ferng, Yh9
Larson, EL9
Leung, GM4
Markel, H5
Milton, DK6
Monto, AS11
Morse, SS9
Navarro, JA5
Park, SY1
Priest, P8
Stebbins, S7
Stern, AM5
Uddin, M11
Wetterhall, SF2
Vukotich Jr, CJ7
 
Issue Date2010
 
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ajic
 
CitationAmerican Journal Of Infection Control, 2010, v. 38 n. 4, p. 251-258 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ajic.2009.12.007
 
AbstractIn June 2006, the Centers for Disease Control and Prevention released a request for applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical interventions (NPIs)-strategies other than vaccines and antiviral medications-to mitigate the spread of pandemic influenza within communities and across international borders (RFA-CI06-010). These studies have provided major contributions to seasonal and pandemic influenza knowledge. Nonetheless, key concerns were identified related to the acceptability and protective efficacy of NPIs. Large-scale intervention studies conducted over multiple influenza epidemics, as well as smaller studies in controlled laboratory settings, are needed to address the gaps in the research on transmission and mitigation of influenza in the community setting. The current novel influenza A (H1N1) pandemic underscores the importance of influenza research. © 2010 Association for Professionals in Infection Control and Epidemiology, Inc.
 
ISSN0196-6553
2012 Impact Factor: 2.731
2012 SCImago Journal Rankings: 1.158
 
DOIhttp://dx.doi.org/10.1016/j.ajic.2009.12.007
 
ISI Accession Number IDWOS:000276979600001
Funding AgencyGrant Number
Centers for Disease Control and PreventionRFA-CI06-010
Funding Information:

The authors thank Martin Cetron, MD and Donald S. Burke, MD for their leadership in the overall research effort. This work would not have been possible without the assistance and editorial comments from CDC Project Officers and Staff: Mary M. Agocs, MD, Francisco Alvarado-Ramy, MD, Paul Edelson, MD, Anthony Fiore, MD, Lyn Finelli, DrPH, Dan B. Fishbein, MD, Diane Gross, PhD, Peter M. Houck, MD, William Jackson, MD, Laurie Kamimoto, MD, Jackie Katz, PhD, J. M. Keir, MPH, Harvey Lipman, PhD, Kiren Mitruka, MD, Josh Mott, PhD, Andrew Plummer, MD, Jacquelyn A. Polder, BSN, MPH, David Shay, MD, Mark Simmerman, RN, PhD, Julie Sinclair, DVM, William Thompson, MD, Timothy M. Uyeki, MD, and Steve Waterman, MD. We also thank Leslie Fink for proofreading the manuscript, and Nabiha Megateli-Das and Centers for Disease Control and Prevention administrative staff members Mattie Jackson, Linda Kirk, Trudy Messmer, and Larry Larue for their support of all projects. This research was supported by the Centers for Disease Control and Prevention under a series of cooperative agreements named herein, emanating from RFA-CI06-010, issued on June 16, 2006.

 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorAiello, AE
 
dc.contributor.authorCoulborn, RM
 
dc.contributor.authorAragon, TJ
 
dc.contributor.authorBaker, MG
 
dc.contributor.authorBurrus, BB
 
dc.contributor.authorCowling, BJ
 
dc.contributor.authorDuncan, A
 
dc.contributor.authorEnanoria, W
 
dc.contributor.authorFabian, MP
 
dc.contributor.authorFerng, Yh
 
dc.contributor.authorLarson, EL
 
dc.contributor.authorLeung, GM
 
dc.contributor.authorMarkel, H
 
dc.contributor.authorMilton, DK
 
dc.contributor.authorMonto, AS
 
dc.contributor.authorMorse, SS
 
dc.contributor.authorNavarro, JA
 
dc.contributor.authorPark, SY
 
dc.contributor.authorPriest, P
 
dc.contributor.authorStebbins, S
 
dc.contributor.authorStern, AM
 
dc.contributor.authorUddin, M
 
dc.contributor.authorWetterhall, SF
 
dc.contributor.authorVukotich Jr, CJ
 
dc.date.accessioned2012-06-26T06:26:53Z
 
dc.date.available2012-06-26T06:26:53Z
 
dc.date.issued2010
 
dc.description.abstractIn June 2006, the Centers for Disease Control and Prevention released a request for applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical interventions (NPIs)-strategies other than vaccines and antiviral medications-to mitigate the spread of pandemic influenza within communities and across international borders (RFA-CI06-010). These studies have provided major contributions to seasonal and pandemic influenza knowledge. Nonetheless, key concerns were identified related to the acceptability and protective efficacy of NPIs. Large-scale intervention studies conducted over multiple influenza epidemics, as well as smaller studies in controlled laboratory settings, are needed to address the gaps in the research on transmission and mitigation of influenza in the community setting. The current novel influenza A (H1N1) pandemic underscores the importance of influenza research. © 2010 Association for Professionals in Infection Control and Epidemiology, Inc.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationAmerican Journal Of Infection Control, 2010, v. 38 n. 4, p. 251-258 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ajic.2009.12.007
 
dc.identifier.citeulike9333081
 
dc.identifier.doihttp://dx.doi.org/10.1016/j.ajic.2009.12.007
 
dc.identifier.epage258
 
dc.identifier.isiWOS:000276979600001
Funding AgencyGrant Number
Centers for Disease Control and PreventionRFA-CI06-010
Funding Information:

The authors thank Martin Cetron, MD and Donald S. Burke, MD for their leadership in the overall research effort. This work would not have been possible without the assistance and editorial comments from CDC Project Officers and Staff: Mary M. Agocs, MD, Francisco Alvarado-Ramy, MD, Paul Edelson, MD, Anthony Fiore, MD, Lyn Finelli, DrPH, Dan B. Fishbein, MD, Diane Gross, PhD, Peter M. Houck, MD, William Jackson, MD, Laurie Kamimoto, MD, Jackie Katz, PhD, J. M. Keir, MPH, Harvey Lipman, PhD, Kiren Mitruka, MD, Josh Mott, PhD, Andrew Plummer, MD, Jacquelyn A. Polder, BSN, MPH, David Shay, MD, Mark Simmerman, RN, PhD, Julie Sinclair, DVM, William Thompson, MD, Timothy M. Uyeki, MD, and Steve Waterman, MD. We also thank Leslie Fink for proofreading the manuscript, and Nabiha Megateli-Das and Centers for Disease Control and Prevention administrative staff members Mattie Jackson, Linda Kirk, Trudy Messmer, and Larry Larue for their support of all projects. This research was supported by the Centers for Disease Control and Prevention under a series of cooperative agreements named herein, emanating from RFA-CI06-010, issued on June 16, 2006.

 
dc.identifier.issn0196-6553
2012 Impact Factor: 2.731
2012 SCImago Journal Rankings: 1.158
 
dc.identifier.issue4
 
dc.identifier.pmid20226569
 
dc.identifier.scopuseid_2-s2.0-77951979047
 
dc.identifier.spage251
 
dc.identifier.urihttp://hdl.handle.net/10722/151708
 
dc.identifier.volume38
 
dc.languageeng
 
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ajic
 
dc.publisher.placeUnited States
 
dc.relation.ispartofAmerican Journal of Infection Control
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshDisease Outbreaks - Prevention & Control
 
dc.subject.meshDisease Transmission, Infectious - Prevention & Control
 
dc.subject.meshHumans
 
dc.subject.meshInfluenza, Human - Epidemiology - Prevention & Control - Transmission
 
dc.subject.meshIntervention Studies
 
dc.titleResearch findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Aiello, AE</contributor.author>
<contributor.author>Coulborn, RM</contributor.author>
<contributor.author>Aragon, TJ</contributor.author>
<contributor.author>Baker, MG</contributor.author>
<contributor.author>Burrus, BB</contributor.author>
<contributor.author>Cowling, BJ</contributor.author>
<contributor.author>Duncan, A</contributor.author>
<contributor.author>Enanoria, W</contributor.author>
<contributor.author>Fabian, MP</contributor.author>
<contributor.author>Ferng, Yh</contributor.author>
<contributor.author>Larson, EL</contributor.author>
<contributor.author>Leung, GM</contributor.author>
<contributor.author>Markel, H</contributor.author>
<contributor.author>Milton, DK</contributor.author>
<contributor.author>Monto, AS</contributor.author>
<contributor.author>Morse, SS</contributor.author>
<contributor.author>Navarro, JA</contributor.author>
<contributor.author>Park, SY</contributor.author>
<contributor.author>Priest, P</contributor.author>
<contributor.author>Stebbins, S</contributor.author>
<contributor.author>Stern, AM</contributor.author>
<contributor.author>Uddin, M</contributor.author>
<contributor.author>Wetterhall, SF</contributor.author>
<contributor.author>Vukotich Jr, CJ</contributor.author>
<date.accessioned>2012-06-26T06:26:53Z</date.accessioned>
<date.available>2012-06-26T06:26:53Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>American Journal Of Infection Control, 2010, v. 38 n. 4, p. 251-258</identifier.citation>
<identifier.issn>0196-6553</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/151708</identifier.uri>
<description.abstract>In June 2006, the Centers for Disease Control and Prevention released a request for applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical interventions (NPIs)-strategies other than vaccines and antiviral medications-to mitigate the spread of pandemic influenza within communities and across international borders (RFA-CI06-010). These studies have provided major contributions to seasonal and pandemic influenza knowledge. Nonetheless, key concerns were identified related to the acceptability and protective efficacy of NPIs. Large-scale intervention studies conducted over multiple influenza epidemics, as well as smaller studies in controlled laboratory settings, are needed to address the gaps in the research on transmission and mitigation of influenza in the community setting. The current novel influenza A (H1N1) pandemic underscores the importance of influenza research. &#169; 2010 Association for Professionals in Infection Control and Epidemiology, Inc.</description.abstract>
<language>eng</language>
<publisher>Mosby, Inc. The Journal&apos;s web site is located at http://www.elsevier.com/locate/ajic</publisher>
<relation.ispartof>American Journal of Infection Control</relation.ispartof>
<subject.mesh>Disease Outbreaks - Prevention &amp; Control</subject.mesh>
<subject.mesh>Disease Transmission, Infectious - Prevention &amp; Control</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Influenza, Human - Epidemiology - Prevention &amp; Control - Transmission</subject.mesh>
<subject.mesh>Intervention Studies</subject.mesh>
<title>Research findings from nonpharmaceutical intervention studies for pandemic influenza and&#160;current gaps in the research</title>
<type>Article</type>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1016/j.ajic.2009.12.007</identifier.doi>
<identifier.pmid>20226569</identifier.pmid>
<identifier.scopus>eid_2-s2.0-77951979047</identifier.scopus>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-77951979047&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>38</identifier.volume>
<identifier.issue>4</identifier.issue>
<identifier.spage>251</identifier.spage>
<identifier.epage>258</identifier.epage>
<identifier.isi>WOS:000276979600001</identifier.isi>
<publisher.place>United States</publisher.place>
<identifier.citeulike>9333081</identifier.citeulike>
</item>
Author Affiliations
  1. Hawaii State Department of Health
  2. Public Health and Social Policy Division
  3. Harvard University
  4. The University of Hong Kong
  5. University of Michigan Medical School
  6. School of Public Policy
  7. University of Pittsburgh Graduate School of Public Health
  8. University of Otago
  9. Columbia University Medical Center
  10. UC Berkeley
  11. University of Michigan School of Public Health
  12. University of Massachusetts Lowell